Summary and general discussion 181 35. Birnie DH, Wang J, Alings M, Philippon F, Parkash R, Manlucu J, et al. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices. J Am Coll Cardiol. 2019;74(23):2845-54. 36. Correction. J Am Coll Cardiol. 2020;76(6):762. 37. Wilkoff BL, Boriani G, Mittal S, Poole JE, Kennergren C, Corey GR, et al. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial. Circ Arrhythm Electrophysiol. 2020;13(10):e008503. 38. de Heide J, van der Graaf M, Holl MJ, Hoogendijk MG, Bhagwandien RE, Wijchers SA, et al. Device infection in patients undergoing pacemaker or defibrillator surgery: risk stratification using the PADIT score. J Interv Card Electrophysiol. 2024. 39. Yap SC, Bhagwandien RE, Theuns D, Yasar YE, de Heide J, Hoogendijk MG, et al. Efficacy and safety of transvenous lead extraction using a liberal combined superior and femoral approach. J Interv Card Electrophysiol. 2021;62(2):239-48. 40. Raatikainen MJP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, et al. A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association. Europace. 2017;19(suppl_2):ii1-ii90. 41. Ministerie van Volksgezondheid Welzijn en Sport. Verbetersignalement zinnige zorg implanteerbare cardioverter-defibrillator (icd)2023; 81. 42. Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B, et al. Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study. Journal of the American College of Cardiology. 2016;67(11):1300-8. 43. Sridhar ARM, Yarlagadda V, Yeruva MR, Kanmanthareddy A, Vallakati A, Dawn B, et al. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study. EP Europace. 2015;17(10):1548-54. 44. USLAN DZ, GLEVA MJ, WARREN DK, MELA T, CHUNG MK, GOTTIPATY V, et al. Cardiovascular Implantable Electronic Device Replacement Infections and Prevention: Results from the REPLACE Registry. Pacing and Clinical Electrophysiology. 2012;35(1):81-7. 45. Fender AC, Dobrev D. Recent highlights on specific aspects of oral anticoagulation in difficult clinical scenarios from the International Journal of Cardiology Heart & Vasculature. Int J Cardiol Heart Vasc. 2023;48:101260. 46. Kotalczyk A, Kalarus Z, Wright DJ, Boriani G, Lip GYH. Cardiac Electronic Devices: Future Directions and Challenges. Med Devices (Auckl). 2020;13:325-38. 47. Deharo JC, Sciaraffia E, Leclercq C, Amara W, Doering M, Bongiorni MG, et al. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI). Europace. 2016;18(5):778-84. 48. Essebag V, Healey JS, Joza J, Nery PB, Kalfon E, Leiria TLL, et al. Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma. Circulation: Arrhythmia and Electrophysiology. 2019;12(10):e007545. 49. Echave M, Oyagüez I, Casado MA. Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review. BMC Surgery. 2014;14(1):111. 50. Burri H, Starck C, Auricchio A, Biffi M, Burri M, D'Avila A, et al. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). Europace. 2021;23(7):983-1008. 51. Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, et al. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm. 2014;11(4):595-601. 52. Shariff N, Eby E, Adelstein E, Jain S, Shalaby A, Saba S, et al. Health and economic outcomes associated with use of an antimicrobial envelope as a standard of care for cardiac implantable electronic device implantation. Journal of cardiovascular electrophysiology. 2015;26(7):783-9. 10
RkJQdWJsaXNoZXIy MTk4NDMw